Concepedia

Publication | Open Access

Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial

DOIFull Paper Access

19

Citations

12

References

2024

Year

B.L. Clarke, Aliya Khan, Mishaela R. Rubin, Peter Schwarz, Tamara Vokes, Dolores Shoback, Claudia Gagnon, Andrea Palermo, Lisa G Abbott, Lorenz C. Hofbauer,
The Journal of Clinical Endocrinology & Metabolism

Abstract

At week 52 of the PaTHway trial, TransCon PTH showed sustained efficacy, safety, and tolerability in adults with hypoparathyroidism.

References

YearCitations

Page 1